发明名称 Uses of anti-CD40 antibodies
摘要 <p>This invention relates to new uses of anti-CD40 antibodies in the treatment of diseases or conditions associated with neoplastic B-cell growth in particular use of anti-CD40 antibodies in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP). The invention is particularly useful for the treatment of patients who have previously been administered (i) CHOP, (ii) the chimeric anti-CD20 monoclonal antibody rituximab, or (iii) combination therapy with CHOP and rituximab.</p>
申请公布号 AU2008323815(A1) 申请公布日期 2009.05.14
申请号 AU20080323815 申请日期 2008.11.07
申请人 NOVARTIS AG;XOMA TECHNOLOGY LTD. 发明人 SEEMA KANTAK;SSUCHENG J. HSU;YONGYU WANG;AMER M. MIRZA;MOHAMMAD LUQMAN
分类号 A61K39/395;A61P35/00 主分类号 A61K39/395
代理机构 代理人
主权项
地址